These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7974589)

  • 1. Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm.
    Willette RN; Zhang H; Mitchell MP; Sauermelch CF; Ohlstein EH; Sulpizio AC
    Stroke; 1994 Dec; 25(12):2450-5; discussion 2456. PubMed ID: 7974589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
    Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endothelin in experimental cerebral vasospasm.
    Roux S; Löffler BM; Gray GA; Sprecher U; Clozel M; Clozel JP
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
    Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
    Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
    Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.
    Zuccarello M; Boccaletti R; Romano A; Rapoport RM
    Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm.
    Cosentino F; McMahon EG; Carter JS; Katusić ZS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs.
    Itoh S; Sasaki T; Ide K; Ishikawa K; Nishikibe M; Yano M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):969-75. PubMed ID: 8373429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.
    Clozel M; Watanabe H
    Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery.
    Bax WA; Aghai Z; van Tricht CL; Wassenaar C; Saxena PR
    Br J Pharmacol; 1994 Dec; 113(4):1471-9. PubMed ID: 7889304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid from patients with subarachnoid haemorrhage and vasospasm enhances endothelin contraction in rat cerebral arteries.
    Assenzio B; Martin EL; Stankevicius E; Civiletti F; Fontanella M; Boccaletti R; Berardino M; Mazzeo A; Ducati A; Simonsen U; Mascia L
    PLoS One; 2015; 10(1):e0116456. PubMed ID: 25629621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
    Shigeno T; Clozel M; Sakai S; Saito A; Goto K
    Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
    Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
    Maguire JJ; Davenport AP
    Br J Pharmacol; 1995 May; 115(1):191-7. PubMed ID: 7647976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade and reversal of endothelin-induced constriction in pial arteries from human brain.
    Pierre LN; Davenport AP
    Stroke; 1999 Mar; 30(3):638-43. PubMed ID: 10066864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].
    Zimmermann M; Seifert V
    Zentralbl Neurochir; 1996; 57(3):143-9. PubMed ID: 8967274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.